Florida Patient with MicroVascular Angina Benefits from EECP® Therapy
Dr. Ken Kronhaus, Lake Cardiology in Mount Dora Discusses the Benefits of EECP® Therapy
January 10, 2012 (Westbury, New York) - Dr. Ken Kronhaus, of Lake Cardiology in Mount Dora, Florida has recently appeared on multiple local TV News stations in Florida discussing the benefits of EECP® therapy for angina patients, including those patients who suffer from a specific form of angina called microvascular angina, which is sometimes referred to as cardiac syndrome X. Microvascular angina or cardiac syndrome X results when the tiny arteries in the heart are affected by microvascular disease or damage.
Microvascular disease is different from traditional coronary artery disease in which a waxy substance called plaque builds up in the large coronary arteries. Plaque narrows the heart's large arteries and reduces the flow of oxygen-rich blood to the heart muscle. The buildup of plaque may lead to blood clots, which mostly or completely block blood flow through a coronary artery. In microvascular disease the heart's tiny arteries are affected. Plaque doesn't create blockages in these vessels as it does in the heart's large arteries but it does affect the flow of oxygen-rich blood to the heart muscle causing the symptoms (chest pain, fatigue, shortness of breath) normally associated with coronary heart disease.
As early as March 2004, Dr. Kronhaus presented a paper at the Scientific Sessions of the American College of Cardiology entitled the Long-Term Improvement in Microvascular Angina Patients Treated with Enhanced External Counterpulsation, which was also published in the Journal of the American College of Cardiology that same year. In 2008 he wrote an Editorial, in the International Journal of Cardiology entitled Enhanced External Counterpulsation is an Effective Treatment for Syndrome X. Dr. Kronhaus been providing EECP® therapy at Lake Cardiology in Mount Dora, Florida since 2000.
For a transcript of the in depth interview with Dr. Kronhaus, please click here.
For the video, please click here.